Sermaglutide regulate the blood sugar/GLP-1 CAS 910463-68-2

Product introduction:

ProName:Semaglutide

CasNo:910463-68-2

Molecular Formula:C187H291N45O59

Appearance:White powder

Application:Regulate blood sugar content/GLP-1

DeliveryTime:5-7days

PackAge:Bottle

Port:Shenzhen

Purity:99%

Storage:Sealed, protected from light, and stored at -20℃+5℃

Transportation:cool chain

LimitNum:5 Gram/1 box

Valid Period:two year

Bacterial endotoxins:<5 EU/mg

Microbial limit:<10 cfu/g

Product Details:

Sermaglutide, more commonly referred to as semaglutide, is a medication used to treat type 2 diabetes and obesity. It belongs to a class of drugs known as GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists). Here are some key points about semaglutide:

1. Mechanism of Action: Semaglutide mimics the GLP-1 hormone, which is involved in the regulation of blood sugar levels and appetite. By activating GLP-1 receptors, it helps to increase insulin secretion in response to meals, reduce glucagon release, slow gastric emptying, and decrease appetite.

2. Uses:

   - Type 2 Diabetes: Semaglutide is used to improve blood sugar control in adults with type 2 diabetes. It can be used alone or in combination with other medications.

   - Obesity: It is also prescribed for weight management in individuals who are overweight or obese, particularly those with weight-related health issues.

3. Administration: Semaglutide is available in several forms, including a once-weekly injection (sold under brand names like Ozempic) and a daily oral tablet (sold as Rybelsus). There's also a higher-dose version used specifically for weight management (sold as Wegovy).

4. Benefits:

   - Blood Sugar Control: Helps lower blood sugar levels effectively in patients with type 2 diabetes.

   - Weight Loss: Aids in significant weight loss, which is beneficial for both diabetes management and overall health.

   - Cardiovascular Benefits: Has shown potential in reducing the risk of major cardiovascular events in individuals with type 2 diabetes and established cardiovascular disease.

5. Side Effects: Common side effects include nausea, vomiting, diarrhea, abdominal pain, and constipation. Some patients may experience more severe side effects, such as pancreatitis or kidney problems.

6. Considerations: Not suitable for everyone, especially those with a history of certain medical conditions like medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. It's important for individuals to discuss their medical history and potential risks with their healthcare provider.

Semaglutide has gained attention for its efficacy in both blood sugar management and weight loss, making it a significant advancement in the treatment of type 2 diabetes and obesity.